Geneplus-Beijing Co. Ltd.
Geneplus-Beijing Co. Ltd.
Explore linked clinical trials.10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Timing of ctDNA Testing in Advanced Breast Cancer | Advanced Breast Cancer | Recruiting | Not stated | 2026-09-15 | NCT07681323 | |
| Circulating Tumor DNA (ctDNA) as a Predictive Biomarker for Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H Colorectal Patients | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Not stated | 2026-06-30 | NCT06098560 | |
| Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2026-06-30 | NCT05965557 | |
| Adaptive Therapy for Resected Stage ⅠA2-Ⅱ NSCLC Patients With Undetectable MRD | non-small cell lung carcinoma | Recruiting | Not applicable | 2025-10-02 | NCT06924710 | |
| The PREDICT Study: Prospective Early Detection In a Population at High-risk for Common Malignant Tumor | Early Detection of Cancer | Active, not recruiting | Not stated | 2025-09-04 | NCT04405557 | |
| Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Not stated | 2025-03-25 | NCT05713994 | |
| Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer | Breast Cancer Screening | Recruiting | Not stated | 2025-03-14 | NCT06876610 | |
| The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, uterine disorder | Not yet recruiting | Not stated | 2024-07-18 | NCT06283875 | |
| ctDNA Monitoring in Early Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not stated | 2024-07-18 | NCT04353557 | |
| ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction Chemoimmunotherapy | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Not stated | 2023-04-20 | NCT05822284 |